Set the Path for the Future Health of Pathology
Get Inspired. Influence Others. Make an Impact. Grow personally and professionally at the 2020 Pathologists Leadership Summit.
What You do as a Pathologist Makes a Difference
Learn the importance of pathologists telling their story to their legislators to help make a difference for pathology and make patient care better at the 2020 Pathologists Leadership Summit.
Upcoming EventsView All Events
Feb 29, 2020
LA Grand Hotel Downtown, Los Angeles, CA
Mar 10, 2020
CLMA KnowledgeLab 2020Mar 29, 2020 - Mar 31, 2020
Kentucky International Convention Center, Louisville, KY
Apr 3, 2020 - Apr 4, 2020
Sheraton Harrisburg Hershey Hotel, Harrisburg, PA
Latest News from the CAP
CAP Opens Comment Period for MMR/MSI Testing, Advancing Care for Patients with CancerRead More
CAP Supports the House Ways and Means Framework to End Surprise Medical BillsRead More
CAP Brings Laboratory Expertise to Dubai ConferenceRead More
Updated Breast Cancer Guideline Refines Testing to Better Identify Patients Likely to Benefit from TreatmentRead More
The Latest on the Novel Coronavirus (Covid-19)
CAP Inspections Delayed in Select Countries
The CAP has postponed all scheduled and requested laboratory inspections in select countries until at least May 1, 2020. This temporary delay is currently limited to China, South Korea, Japan, Taiwan, and Italy. This list is subject to change depending on the scope of the outbreak. During this time, impacted laboratories will remain CAP accredited. Additionally, to maintain quality and safety during this time, impacted laboratories should continue PT participation and follow all CAP requirements.
The U.S. Food and Drug Administration (FDA) continues an emergency use authorization (EUA) for qualified U.S. laboratories to use the novel coronavirus (Covid-19) Real-Time RT-PCR Diagnostic Panel developed by the U.S. Centers for Disease Control and Prevention (CDC).
The CDC is offering interim guidance for laboratory professionals working with clinical specimens from patients under investigation. CDC officials consider the immediate risk here in the US to still be low; however, risk is dependent on exposure (e.g., health care workers caring for patients with Covid-19 and other close contacts are likely to be at greater risk).
The World Health Organization (WHO) declared the coronavirus outbreak meets the criteria for a “Public Health Emergency International Concern.” Representatives from the (WHO) are now on the ground in China. The US State Department issued an updated “Level 4: Do Not Travel” guidance to China, requesting all nonessential US government personnel defer travel to the country. The guidance for prevention of any coronavirus is the same as those outlined for seasonal flu.